Investment in medical devices has a long way to go

, ,
Integral service around a transaction
BY : Diego GutiérrezOctober Fri, 2014
The development of devices applied to healthcare received double the number of financing rounds in 2014, with 51 deals, compared to 21 in 2013. The sector is taking shape and there is still a long way to go before it reaches maturity. This is evidenced by the small but growing number of acquisitions by corporations.

In 2014, 51 rounds were conducted for a total amount of $538M, far exceeding the 24 transactions for a total amount of $200M conducted the previous year.

Slide 3

"In addition, this year the weight of venture rounds in the total number of rounds has also increased compared to last year, which shows us that the medical devices sector is a sector in expansion, in which companies are making great efforts to grow and introduce new products to the market, in a market that is characterised by strong regulation that requires a large amount of resources" says Diego Gutierrez from Abra Invest.



There are several companies that have received a large amount of funding this year alone, leading the list is Xinrong, the Chinese company that sells medical devices has received a $100M round of funding. Blackstone Group. This is a sign of the effort that Asian companies are making to grow in this market, which is led by large American companies.

Second on the list is InSightecIsrael-based company that develops advanced MRI-guided Focused Ultrasound technology. This company has closed 2 rounds of financing in the last year 2014, for a total of $62M.

The third company that has raised the most money is Accelerate Diagnostics. Based in Arizona, an in vitro diagnostics company providing solutions to drug-resistant organisms and hospital-acquired infections, founded in 2004, it has already closed 4 rounds of funding, the latest being $45M.

Sector Funding IT Sector

Slide 4

Among the investors who have bet on the sector, there are several who have made several investments in the sector, leading the list. Delphi Ventureswhich has invested in 6 medical device technology companies. The Californian firm, founded in 1988, has invested more than 1.1Bn$ in more than 170 companies and is focused on biotech and medical device companies.

Acquisitions in the sector

The number of acquisitions in the sector has grown in the last year, although the number of acquisitions is still low. It is worth noting that half of the eight transactions are in the field of cardiovascular medicine. 


Other posts that may interest you

Juan Diego Cuenca, partner of Abra-invest, analyses the biotechnology sector on Gestionaradio 

Biotechnology in Spain finds investors

We are currently preparing a report on the current state of crowdfunding as an alternative means of financing. If you are interested in receiving this report, please leave us your email address.



The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?